3.
3/4级毒性反应的meta分析
Meta-analysis of grade 3/4 toxicities
| Toxicities | Quantity (n) | Observation | Control | Heterogeneity analysis | Effects model | RR (95%CI) | Z | P | |
| I2(%) | P | ||||||||
| Low-does bevacizumab (7.5 mg/kg) | |||||||||
| Leukopenia | 2[3, 6] | 142/362 | 111/359 | 0 | 0.771 | Fixed | 1.27 (1.04-1.55) | 2.32 | 0.020 |
| GI reactions | 2[3, 6] | 29/362 | 14/359 | 0 | 0.789 | Fixed | 2.06 (1.11-3.82) | 2.28 | 0.023 |
| Hypertension | 2[3, 6] | 21/362 | 6/359 | 54.3 | 0.135 | Random | 1.88 (0.19-18.71) | 0.54 | 0.590 |
| Bleeding events | 2[3, 6] | 19/362 | 6/359 | 3.3 | 0.309 | Fixed | 2.75 (1.05-7.21) | 2.06 | 0.039 |
| High-does bevacizumab (15 mg/kg) | |||||||||
| Leukopenia | 6[3-8] | 326/990 | 219/876 | 48.8 | 0.196 | Fixed | 1.33 (1.18-1.49) | 4.10 | 0.020 |
| Anemia | 5[4-8] | 95/1, 286 | 94/1, 235 | 46.6 | 0.096 | Fixed | 0.94 (0.72-1.23) | 0.46 | 0.643 |
| GI reactions | 4[3, 5, 6, 8] | 41/522 | 17/459 | 0 | 0.889 | Fixed | 2.26 (1.31-3.89) | 2.94 | 0.003 |
| Proteinuria | 3[4, 6, 8] | 17/875 | 0/825 | 0.8 | 0.365 | Fixed | 11.5 (2.38-55.73) | 3.03 | 0.002 |
| Hypertension | 6[3-8] | 73/948 | 9/899 | 0 | 0.741 | Fixed | 6.94 (3.59-13.43) | 5.79 | < 0.001 |
| Bleeding events | 5[4-8] | 38/948 | 10/899 | 0 | 0.743 | Fixed | 3.27 (1.67-6.41) | 3.45 | 0.001 |